Effects of Dexmedetomidine on Immune Cells: A Narrative Review

被引:20
作者
Chen, Rui [1 ,2 ]
Sun, Yan [1 ,2 ]
Lv, Jing [1 ,2 ]
Dou, Xiaoke [1 ,2 ]
Dai, Maosha [1 ,2 ]
Sun, Shujun [1 ,2 ]
Lin, Yun [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Inst Anesthesia & Crit Care Med, Tongji Med Coll, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan, Peoples R China
关键词
dexmedetomidine; immune cells; innate immune response; adaptive immune response; inflammatory factors; REGULATORY T-CELLS; MAST-CELLS; PERIOPERATIVE PERIOD; CYTOKINE LEVELS; ADRENERGIC REGULATION; PERIPHERAL-BLOOD; FAMILY CYTOKINES; STRESS-RESPONSE; DOUBLE-BLIND; INFLAMMATION;
D O I
10.3389/fphar.2022.829951
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As we all know, dexmedetomidine (DEX), as a highly selective alpha(2) adrenergic receptor agonist, exerts sedative, anti-anxiety and hypnotic effects by inhibiting the discharge of norepinephrine neurons in locus coeruleus and GABA-related hypnotic pathways. However, the role of DEX in anti-inflammatory and immune regulation has gradually attracted the attention of researchers in recent years. The alpha(2) adrenergic receptor is one of the members of the adrenergic receptor family, which is widely present in a variety of immune cells and mediates the biological behavior of the inflammatory immune system. At present, there have been more and more studies on the effects of DEX on immune cells and inflammatory responses, but few studies have systematically explored the anti-inflammatory and immunomodulatory effects of DEX. Here, we comprehensively review the published human and animal studies related to DEX, summarize the effects of DEX on immune cells and its role in related diseases, and propose potential research direction.
引用
收藏
页数:12
相关论文
共 116 条
[1]   Interleukin 18 in the CNS [J].
Alboni, Silvia ;
Cervia, Davide ;
Sugama, Shuei ;
Conti, Bruno .
JOURNAL OF NEUROINFLAMMATION, 2010, 7
[2]   EFFECTS OF CLONIDINE ON THE DERMAL INFLAMMATORY CELL RESPONSE OF EXPERIMENTAL TOXIC AND ALLERGIC CONTACT REACTIONS AND INTRADERMAL HYPERSENSITIVITY [J].
ANDERSON, CD ;
LINDGREN, BR ;
ANDERSSON, RGG .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1987, 83 (04) :371-376
[3]   Extracellular HMGB1 as a therapeutic target in inflammatory diseases [J].
Andersson, Ulf ;
Yang, Huan ;
Harris, Helena .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (03) :263-277
[4]   B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion [J].
Barbera-Guillem, E ;
Nelson, MB ;
Barr, B ;
Nyhus, JK ;
May, KF ;
Feng, L ;
Sampsel, JW .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) :541-549
[5]   LOCALIZATION OF MESSENGER-RNA FOR 3 DISTINCT ALPHA(2)-ADRENERGIC RECEPTOR SUBTYPES IN HUMAN TISSUES - EVIDENCE FOR SPECIES HETEROGENEITY AND IMPLICATIONS FOR HUMAN PHARMACOLOGY [J].
BERKOWITZ, DE ;
PRICE, DT ;
BELLO, EA ;
PAGE, SO ;
SCHWINN, DA .
ANESTHESIOLOGY, 1994, 81 (05) :1235-1244
[6]   Sleep and immune function [J].
Besedovsky, Luciana ;
Lange, Tanja ;
Born, Jan .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2012, 463 (01) :121-137
[7]   Dexmedetomidine [J].
Bhana, N ;
Goa, KL ;
McClellan, KJ .
DRUGS, 2000, 59 (02) :263-268
[8]   The Interactions of Multiple Cytokines Control NK Cell Maturation [J].
Brady, Jason ;
Carotta, Sebastian ;
Thong, Rebecca P. L. ;
Chan, Christopher J. ;
Hayakawa, Yoshihiro ;
Smyth, Mark J. ;
Nutt, Stephen L. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (11) :6679-6688
[9]   RETRACTED: In vivo effects of dexmedetomidine on immune function and tumor growth in rats with ovarian cancer through inhibiting the p38MAPK/NF-κB signaling pathway (Retracted Article) [J].
Cai, Qi-Hang ;
Tang, Yao ;
Fan, Shao-Hua ;
Zhang, Zi-Feng ;
Li, Hong ;
Huang, Shao-Qiang ;
Wu, Dong-Mei ;
Lu, Jun ;
Zheng, Yuan-Lin .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 :1830-1837
[10]   PERIOPERATIVE PERIOD: IMMUNOLOGICAL MODIFICATIONS [J].
Cardinale, F. ;
Chinellato, I. ;
Caimmi, S. ;
Peroni, D. G. ;
Franceschini, F. ;
Del Giudice, M. Miraglia ;
Bernardini, R. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 :3-11